Elevance Health Inc. (ELV) Tops Q3 EPS by 54c; updates Guidance

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.99, $0.54 better than the analyst estimate of $8.45. Revenue for the quarter came in at $42.48 billion versus the consensus estimate of $42.76 billion.

GUIDANCE:

Elevance Health Inc. sees FY2023 adjusted EPS to be greater than $33.00, versus the consensus of $32.93.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• UBS Reiterates Buy Rating on Elevance (ELV)
• MP Materials seen largely insulated after China export-control move